Gideon Capital Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,578	Closed	-$495K	–	282
2019 Q1	$495K	Sell	5,578 -3,585	-39%	-$332K	0.18%	170
2018 Q4	$780K	Buy	9,163 +4,124	+82%	+$392K	0.32%	92
2018 Q3	$489K	Buy	5,039 +677	+16%	+$67.6K	0.23%	148
2018 Q2	$411K	Buy	+4,362	New	+$382K	0.21%	187
2018 Q1	–	Sell	-2,862	Closed	-$255K	–	351
2017 Q4	$255K	Sell	2,862 -1,536	-35%	-$134K	0.22%	200
2017 Q3	$409K	Buy	4,398 +2,088	+90%	+$185K	0.4%	72
2017 Q2	$210K	Sell	2,310 -1,721	-43%	-$157K	0.23%	223
2017 Q1	$354K	Sell	4,031 -1,922	-32%	-$171K	0.21%	191
2016 Q4	$494K	Buy	+5,953	New	+$512K	0.32%	92
2014 Q3	–	Sell	-11,941	Closed	-$743K	–	273
2014 Q2	$743K	Buy	+11,941	New	+$721K	0.27%	120